Global Breast Biopsy Market 2017-2021

  • ID: 4143897
  • Report
  • Region: Global
  • 70 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Argon Medical Devices
  • Biopsybell
  • Cook Medical
  • Imaging Equipment
  • Metaltronica
  • Planmed OY
  • MORE
About Breast Biopsy

A breast biopsy is a procedure that involves the removal of tissue or fluid from the targeted area. The tissue is examined under a microscope and then tested to determine the presence of breast cancer. A biopsy is the only diagnostic procedure to confirm cancer. About 80% of women who undergo breast biopsy do not have breast cancer.

The analysts forecast the global breast biopsy market to grow at a CAGR of 10.70% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global breast biopsy market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of breast biopsy devices.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

The report, Global Breast Biopsy Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- BD
- C.R. Bard
- Hologic
- Leica Biosystems

Other prominent vendors
- Argon Medical Devices
- Aurora Imaging
- Biopsybell
- Bracco Imaging
- Carestream Health
- Cook Medical
- Fischer Medical Technologies
- Imaging Equipment
- Intact Medical (a subsidiary of Medtronic)
- Internazionale Medico Scientifica
- Metaltronica
- NuVue Therapeutics
- PerkinElmer
- Planmed OY
- Sectra
- STERYLAB
- Terason
- ZAMAR CARE
Market drivers
- Growing incidence of breast cancer
- For a full, detailed list, view the full report

Market challenges
- Complications and risks associated with breast biopsies
- For a full, detailed list, view the full report

Market trends
- Increase in reimbursement for breast biopsy
- For a full, detailed list, view the full report

Key questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the Key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Argon Medical Devices
  • Biopsybell
  • Cook Medical
  • Imaging Equipment
  • Metaltronica
  • Planmed OY
  • MORE
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
  • Key market highlights
  • Top-vendor offerings
PART 05: Breast cancer: An overview
  • Background
  • Breast cancer
  • Breast biopsy
PART 06: Market landscape
  • Market overview
  • Market size and forecast
  • Five forces analysis
PART 07: Market segmentation by product type
  • Market overview
  • Global breast biopsy imaging guidance systems market
  • Global breast biopsy needles market
  • Global breast biopsy needle-based systems market
  • Others
PART 08: Market segmentation by modality
  • Global breast biopsy market by modality
PART 09: Market segmentation by end-user
  • Hospitals
  • ASCs
  • Research centers
  • Others
PART 10: Geographical segmentation
  • Breast biopsy market in Americas
  • Breast biopsy market in EMEA
  • Breast biopsy market in APAC
PART 11: Decision framework

PART 12: Drivers and challenges
  • Market drivers
  • Impact of drivers on key customer segments
  • Market challenges
  • Impact of challenges on key customer segments
PART 13: Market trends
  • Increase in reimbursement for breast biopsy
  • Growing demand for MRI and ultrasound-guided breast biopsy procedures
  • Emergence of breast liquid biopsy tests
PART 14: Vendor landscape
  • Competitive landscape
PART 15: Key vendor analysis
  • BD
  • C.R. Bard
  • Hologic
  • Leica Biosystems
  • Other prominent vendors
PART 16: Appendix
  • List of abbreviations
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Percentage of cancer types worldwide 2012
Exhibit 03: Breast cancer stages by tumor size and extent of metastasis
Exhibit 04: Snapshot of global breast biopsy market
Exhibit 05: Global breast biopsy market 2016-2021 ($ millions)
Exhibit 06: Five forces analysis
Exhibit 07: Global breast biopsy market by product type
Exhibit 08: Most common biopsies for breast cancer
Exhibit 09: Global breast biopsy market by product type 2016-2021
Exhibit 10: Global breast biopsy market by product analysis 2016
Exhibit 11: Global breast biopsy market growth lifecycle analysis 2016
Exhibit 12: Global breast biopsy market by product 2016-2021 ($ millions)
Exhibit 13: Global breast biopsy market by product 2016-2021 (%)
Exhibit 14: Global breast biopsy imaging guidance systems market 2016-2021 ($ millions)
Exhibit 15: Benefits of advanced biopsy needles
Exhibit 16: Global breast biopsy needles market 2016-2021 ($ millions)
Exhibit 17: Global needle-based breast biopsy systems market 2016-2021 ($ millions)
Exhibit 18: Global other breast biopsy devices market 2016-2021 ($ millions)
Exhibit 19: Global breast biopsy market by modality
Exhibit 20: Global breast biopsy market by modality 2016 (%)
Exhibit 21: Global breast biopsy market by end-user 2016
Exhibit 22: Global breast biopsy market by geography 2016-2021
Exhibit 23: Global breast biopsy market analysis by geography 2016
Exhibit 24: Geographical presence of global breast biopsy market
Exhibit 25: Geographical overview of global breast biopsy market 2016-2021
Exhibit 26: Breast biopsy market in Americas 2016-2021 ($ millions)
Exhibit 27: Estimated number of new cancer cases and deaths in US 2016 (1000s)
Exhibit 28: Top four EMEA countries population over 65 years of age 2015 (%)
Exhibit 29: Breast biopsy market in EMEA 2016-2021 ($ millions)
Exhibit 30: Breast biopsy market in APAC 2016-2021 ($ millions)
Exhibit 31: Global breast biopsy market by geography 2016-2021 ($ millions)
Exhibit 32: Global breast biopsy market by geography 2016-2021 (%)
Exhibit 33: Government initiatives for cancer and liquid biopsy testing in some countries
Exhibit 34: Impact of drivers
Exhibit 35: Cost of biopsies for uninsured people in US 2015
Exhibit 36: Impact of challenges
Exhibit 37: Breast biopsy facility payment in US
Exhibit 38: Competitive structure of global breast biopsy market
Exhibit 39: Competitive parameters in global breast biopsy market
Exhibit 40: Market penetration of breast biopsy market vendors 2016
Exhibit 41: Global breast biopsy market share analysis 2016
Exhibit 42: Key highlights of BD
Exhibit 43: BD: Strength assessment
Exhibit 44: BD: Strategy assessment
Exhibit 45: BD: Opportunity assessment
Exhibit 46: C.R. Bard: Strength assessment
Exhibit 47: C.R. Bard: Strategy assessment
Exhibit 48: C.R. Bard: Opportunity assessment
Exhibit 49: Key highlights of Hologic
Exhibit 50: Hologic: Strength assessment
Exhibit 51: Hologic: Strategy assessment
Exhibit 52: Hologic: Opportunity assessment
Exhibit 53: Key highlights of Leica Biosystems
Exhibit 54: Leica Biosystems: Strength assessment
Exhibit 55: Leica Biosystems: Strategy assessment
Exhibit 56: Leica Biosystems: Opportunity assessment
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Argon Medical Devices
  • Biopsybell
  • Cook Medical
  • Imaging Equipment
  • Metaltronica
  • Planmed OY
  • MORE
New Report Released: – Global Breast Biopsy Market 2017-2021

The author of the report recognizes the following companies as the key players in the global breast biopsy market: BD, C.R. Bard, Hologic, and Leica Biosystems.

Other Prominent Vendors in the market are: Argon Medical Devices, Aurora Imaging, Biopsybell, Bracco Imaging, Carestream Health, Cook Medical, Fischer Medical Technologies, Imaging Equipment, Intact Medical, Internazionale Medico Scientifica, Metaltronica, NuVue Therapeutics, PerkinElmer, Planmed OY, Sectra, STERYLAB, Terason, and ZAMAR CARE.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is increase in reimbursement for breast biopsy. The rise in the number of breast biopsy procedures in the last few years has seen a corresponding increase in reimbursement for breast biopsies. Most of the medical healthcare facilities such as the Centers for Medicare & Medicaid Services (CMS) had fixed payment for bundled breast biopsy devices in 2015. This has leveraged the reimbursement to hospitals by 51% compared with 2014 rates.”

According to the report, one of the major drivers for this market is growing incidence of breast cancer. The rising incidence of breast cancer is fueling the growth of the breast biopsy market worldwide. Breast cancer is the most common cancer prevalent in females and is the second most common cancer overall, after skin cancer. Breast cancer is found to affect men above 50 years of age and is rare in young women.

Further, the report states that one of the major factors hindering the growth of this market is complications and risks associated with breast biopsies. In several reported cases, breast needles biopsies have been known to cause significant complications in patients. The faulty execution of biopsies can cause damage to nearby tissues or organs, as well as skin numbness around the biopsy site. Bruising, infection, mild pain, and prolonged bleeding from the target site are the most common risks during the procedure. The risk of bleeding results in the formation of hematoma during the collection of blood at the biopsy site; however, the risk is seen in less than 1% of the patients. Any surgical procedure, invasive or less invasive, carries risks. The chances of infections are less when performed with antibiotics.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • BD
  • CR Bard
  • Hologic
  • Leica Biosystems
  • Argon Medical Devices
  • Aurora Imaging
  • Biopsybell
  • Bracco Imaging
  • Carestream Health
  • Cook Medical
  • Fischer Medical Technologies
  • Imaging Equipment
  • Intact Medical
  • Internazionale Medico Scientifica
  • Metaltronica
  • NuVue Therapeutics
  • PerkinElmer
  • Planmed OY
  • Sectra
  • STERYLAB
  • Terason
  • ZAMAR CARE
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll